Vagisil® Announces the Launch of Its Preventeza™ Emergency Contraceptive #WeAre1in2 Campaign & Buy-One, Get-One or Give-on...
July 06 2018 - 08:00AM
Business Wire
- 1 in 2 Women May Need to Use Emergency
Contraception in Their Lifetime
- The makers of Vagisil will give away up
to $1 Million Worth Of Free Preventeza Emergency Contraceptive Via
The BoGoGo Product Campaign on Vagisil.com
Combe Inc., the makers of Vagisil®, today announced the launch
of its Preventeza Emergency Contraceptive (levonorgestrel tablet,
1.5 mg) #WeAre1in2 campaign to showcase solidarity around women’s
reproductive rights. To demonstrate its commitment to helping women
learn more about emergency contraception (EC), the Company is
planning to give away up to $1 million worth of free product via
the launch of its “Buy One Get One or Give One (BoGoGo)” product
campaign where women who purchase Preventeza on Vagisil.com will
have the option to get a second one for free to either keep on hand
or to give to another woman in their life.
New Preventeza by Vagisil, available online or over-the-counter
(OTC) as a single tablet, takes the panic out of a stressful
moment, and is a proven option to help women prevent pregnancy
before it starts by using the same ingredient as most birth control
pills, just at a higher dose. By keeping Preventeza on hand, women
can always be prepared and in control.
“We are thrilled about the BoGoGo promotion as it provides us
with the opportunity to educate women about the need for and the
importance of access to emergency contraception (EC). Moreover, it
remains shocking to us that while 1 in 2 women may need an EC in
their lifetime, only 10 percent of women have actually used it,”
said Keech Combe Shetty, CEO of Vagisil. “This is why we are giving
away up to $1 million worth of Preventeza as it aligns with our
mission at Vagisil to empower women to take ownership of their
reproductive health without shame.”
Preventeza’s BoGoGo promotion is available nationwide and can be
activated at checkout online at Vagisil.com. In parallel, the
Company is launching the #WeAre1in2 campaign on social media that
is aimed at increasing awareness of the fact that 1 in 2 women may
need EC in their lifetime due to the risk of unintended
pregnancies. People are encouraged to showcase their solidarity
using #WeAre1in2 on social media.
“It is an important time in the history of our country for women
to gather together on critical issues related to reproductive
health. The fact that 45 percent of pregnancies remain unplanned or
mistimed clearly demonstrates the need for education so women can
understand that there are safe and effective tools that serve as
back-ups for regular birth control in case of unprotected sex or
when birth control fails. In addition to practicing safe sex, there
are EC options, such as Vagisil’s Preventeza, available to all
women of reproductive age,” said Logan Levkoff, PhD, MS, an
internationally recognized expert on sexuality and relationships.
“I am proud that Preventeza is launching a dialogue on this timely
movement that will help to differentiate myths versus facts about
EC while increasing access for all women.”
Preventeza is brought to you by the makers of Vagisil, a trusted
women’s health brand, that encourages women to talk about health
topics they are uncomfortable discussing, provides facts and
resources to help educate, and thereby reduces the shame that still
exists around vaginal and sexual health.
How Preventeza Works
Preventeza can be taken within 72 hours (three days) after
unprotected sex has occurred, yet is most effective the sooner it
is taken. Preventeza works mainly by stopping the release of an egg
from the ovary. Preventeza will not harm an existing pregnancy.
Preventeza does not protect women from HIV infection (the virus
that causes AIDS) and other sexually transmitted diseases
(STDs).
When used as directed, Preventeza can significantly decrease the
chance of a woman becoming pregnant after unprotected sex.
Approximately seven out of every eight women who would have become
pregnant will not after taking Preventeza.
About Preventeza
Preventeza (levonorgestrel tablet, 1.5 mg) is an
over-the-counter (OTC) progestin-only emergency contraceptive
indicated for prevention of pregnancy following unprotected sex or
a known or suspected contraceptive failure. Preventeza can be
purchased direct to consumers online via Vagisil.com or Amazon.com
or in drug and food retailers. The BoGoGo promotion is available
only at Vagisil.com. To learn more about Preventeza, please visit
Vagisil.com.
About Combe Incorporated
Combe Inc., “the most personal Personal Care company in the
world,” is a privately held manufacturer and marketer of personal
care, beauty, and over-the-counter (OTC) drug products. Its women’s
health brands include Vagisil, a trusted line of feminine products,
which for the past 40 years has been dedicated to creating
effective vaginal health solutions and an open forum to address
issues that affect women most. Founded in 1949, Combe Inc. is in
the third generation of its family leadership, with global
headquarters in White Plains, New York. To learn more about
Vagisil, please visit Vagisil.com. To learn more about Combe Inc.,
please visit Combe.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180706005035/en/
RXMD for Combe Inc.Sophia Ononye,
646-599-8630combe@rxmedyn.com